She is also currently the recipient of an Thomas Edison Innovation Fellowship and a Leonardo da Vinci Fellowship Grant, both from the center, for a large historical and empirical project relating to restoration of patent terms for pharmaceuticals.
At the School of Law, Professor Lietzan teaches and writes in the areas of drug and device regulation, intellectual property and administrative law. Her primary research focus lies at the intersection of intellectual property law and FDA regulation of medical products. Her recent scholarship has focused on the new drug research and development paradigm and its impact on incentives to innovate, innovation and competition in the marketplace for biological medicines, the incentive for generic drug applicants to challenge innovator patents, data exclusivity for drug and biological medicine innovators, and mandatory public disclosure of clinical data in drug applications, among other issues. Her articles can be downloaded here.